CClinicalTrials.gg
CompletedNCT01170793CAM-ETUpdated May 29, 2026

Medicine Abuse Headache

An interventional study of educative telephone coaching (ETC) in Migraine, sponsored by University Hospital, Bordeaux. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-29.

Sponsored by University Hospital, Bordeaux · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In patients with MOH, we will evaluate the impact of educative telephone coaching on the number of days with headache over the month preceding the appointment. The educative coaching will be administered by a nurse, during a single phone call and prior to the medical visit

Read the detailed description

In tertiary centers, it is not unusual for patients to wait for 6 months for a medical appointment. This clinical trial is monocentric, open, randomised. In the first arm, the patients will receive educative telephone coaching at Month 2 by the nurses, over the phone. In the second arm, the patients will not receive any educative telephone coaching before the appointment with the neurologist.

All patients will complete "Quality of life" questionnaires at Month 1 and Months 6, complete a migraine agenda during the length of the study and have a medical appointment around Month 6.

The primary outcome will be the efficacy of such educative telephone coaching, administered before the medical appointment in the Chronic Pain Center, in Bordeaux. It will be measured by the number of days with headache over the month preceding the appointment.

02

Conditions studied

  • Migraine

Browse trials for

Keywords

  • education, quality of life
03

In context

Migraine Disorders

1,528 studies on the registry are indexed under Migraine Disorders; 299 are open to participants now.

This study's enrollment of 88 is close to the median of 80 across 1,175 interventional studies indexed under Migraine Disorders.

Browse Migraine Disorders studies →

Lead sponsor

University Hospital, Bordeaux is the lead sponsor of 783 studies on the registry; 188 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults, male or female, > 18 years old
  • Patients with a presumptive medication overuse headache diagnostic (>15 days/month with migraines, > 10 days/month intake of crisis treatment)
  • Persons calling the Chronic Pain Center in Bordeaux and asking for a medical appointment
  • Informed and written consent, dated and signed by the patient and the investigator prior to any study related procedure

Exclusion criteria

Exclusion Criteria:

  • Patients with a differential diagnostic (other primitive headaches and secondary headaches)
  • Persons non affiliated to a social security system
  • Persons who refuse to participate in the study.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
88 participants (actual)

Study arms

  • No intervention
    2

    no educative telephone coaching (ETC)

  • Experimental
    1

    with educative telephone coaching (ETC)

    Behavioral: educative telephone coaching (ETC)

Interventions

  • Behavioraleducative telephone coaching (ETC)

    a 30 to 45 minutes phone call, by appointment, by the nurse

06

What researchers measure

Primary outcomes

  1. To evaluate the efficacy of educative telephone coaching administered by the center's nurses prior to the medical on-site visit.

    Time frame: within 6 months

Secondary outcomes

  1. To evaluate the efficacy of educative telephone coaching (ETC) on the frequency of headaches and on the number of days with crisis treatment intake.

    Time frame: within 6 months

  2. To evaluate the efficacy of ETC on the patients quality of life and their handicap (emotional, professional and familial data)

    Time frame: within 6 months

  3. To evaluate the patient's satisfaction toward ETC

    Time frame: within 6 months

  4. To evaluate the patient's knowledge concerning migraine, medication overuse headache and their treatment after ETC

    Time frame: within 6 months

  5. To estimate the cost/benefits ratio of ETC and its impact on medical costs ahead of the medical appointment.

    Time frame: within 6 months

07

Study locations

1 site
  • Centre Douleur Chronique - Groupe Hospitalier Pellegrin - Bât USN Tastet Girard
    Bordeaux, 33076, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01170793
Lead sponsor
University Hospital, Bordeaux
Collaborators
Fondation Apicil
Responsible party
Sponsor
First posted
Jul 27, 2010
Start date
Aug 2010
Primary completion
Jun 2012
Completion
Jun 2012
Last update
May 29, 2026

Study contacts

Geneviève Chene, MD PhD
study chair · University Hospital, Bordeaux
Virginie Dousset, MD
principal investigator · University Hospital, Bordeaux

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion